A meningitis shot is a vaccine that protects against meningococcal disease, a bacterial infection that causes inflammation of the membranes surrounding the brain and spinal cord. About 1 in 6 people who develop bacterial meningitis die from it, and 1 in 5 survivors experience lasting complications like hearing loss, seizures, or limb amputations. The vaccine is routinely given to preteens and teenagers, with additional doses recommended for college students and certain high-risk groups.
Types of Meningitis Vaccines
The bacteria that cause meningococcal disease come in several serogroups, and different vaccines target different ones. There are three main categories available in the United States:
- MenACWY vaccines protect against four serogroups: A, C, W, and Y. This is the one most people get as preteens. Brand names include Menveo and MenQuadfi.
- MenB vaccines protect specifically against serogroup B, which is responsible for the majority of college campus outbreaks. Brand names include Bexsero and Trumenba.
- MenABCWY vaccines are newer pentavalent vaccines that cover all five serogroups (A, B, C, W, and Y) in a single shot. Penbraya, approved for people ages 10 to 25, is the first of this type and combines coverage that previously required two separate vaccine series.
When and How Many Doses You Need
The standard schedule for MenACWY starts with a single dose at age 11 or 12, followed by a booster at age 16. That booster timing matters because protection fades over time. In the first year after vaccination, effectiveness against serogroups A, C, W, and Y sits around 79%, but it drops to about 61% by three to eight years out. The age-16 booster restores protection right when the risk of exposure climbs highest.
If a teen misses the first dose and gets vaccinated between ages 13 and 15, the booster is given between 16 and 18.
MenB vaccination works on a different timeline. The CDC recommends two doses spaced six months apart, ideally between ages 16 and 18 to cover the peak-risk years. Students heading to college with less than six months before move-in can use an accelerated three-dose schedule to build protection faster.
Why College Students Are a Focus
Adolescents and young adults between 16 and 23 have the highest rates of serogroup B meningococcal infections. Crowded dorm living, shared spaces, and social behaviors common in this age group (close contact at parties, intimate kissing) all increase the chance of spreading the bacteria through respiratory secretions. Between 2011 and 2019, serogroup B caused every meningococcal outbreak on U.S. college campuses, affecting 13 schools, causing 50 cases, and killing 2 students.
Many states now require proof of MenACWY vaccination for college enrollment. Requirements for MenB vaccination are less universal but growing, partly because campus outbreaks are difficult to control once they start.
Who Else Should Get Vaccinated
Beyond the routine preteen and teen schedule, certain medical conditions put people at higher risk for severe meningococcal disease. The CDC recommends both MenACWY and MenB vaccines for people with complement component deficiencies (problems with part of the immune system that fights bacteria), anyone without a functioning spleen (including people with sickle cell disease), and those living with HIV, who should receive MenACWY.
Travel is another common reason adults get vaccinated. Sub-Saharan Africa’s “meningitis belt” has the world’s highest rates of meningococcal disease, and travelers visiting during the meningitis season (December through June) should receive a MenACWY vaccine beforehand. Saudi Arabia requires documentation of meningococcal vaccination for anyone making the Hajj or Umrah pilgrimage, with the vaccine given no more than five years before arrival.
Side Effects
Meningitis vaccines are well tolerated. The MenACWY shot commonly causes soreness or redness at the injection site, along with muscle pain, headache, and fatigue. These typically resolve within a day or two.
MenB and the newer MenABCWY vaccines tend to produce slightly more noticeable side effects. In addition to injection-site soreness and swelling, you may experience fatigue, headache, muscle or joint pain, fever, chills, nausea, or diarrhea. These reactions are temporary and reflect the immune system responding to the vaccine, not signs of infection.
The only true contraindication for either vaccine type is a history of severe allergic reaction (anaphylaxis) to a previous dose or to any ingredient in the vaccine. This is rare.
How Long Protection Lasts
Protection from a single MenACWY dose fades meaningfully over a few years. Antibody levels drop noticeably within about two years and continue declining through the five-year mark, though the rate of decline levels off after that. This waning is why the booster dose at 16 is so important for teens vaccinated at 11 or 12. People with ongoing risk factors, such as certain medical conditions or continued exposure through travel, may need additional boosters on a schedule their provider can outline.
For MenB vaccines, the duration of protection is less precisely defined, but a completed two- or three-dose series is designed to cover the highest-risk window through the late teens and early twenties.